That is a crap comment and you know it. Stop the crap! This was a reverse-merger. New management team, except old CEO is co-CEO who happens to have a biotech background. Don't think LIFE Technologies would partner with a #$%$ firm. It's not like CLRX partnered with shortstadamus on an #$%$ fusion drug. Keep shorting buddy.
This was not a reverse merger. Tegal acquired CollabRx, a private company. Tegal issued 236,433 shares to CollabRX and assumed $500,000 of CollabRx indebtedness.
A reverse merger occurs when a privately held company acquires a publicly traded company. That did not happen here.